Your browser doesn't support javascript.
loading
Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.
Patel, Kishan A; Calomeni, Edward P; Nadasdy, Tibor; Zynger, Debra L.
Affiliation
  • Zynger DL; Department of Pathology, The Ohio State University Medical Center, 410 W 10th Ave, 401 Doan Hall, Columbus, OH 43210, USA. debra.zynger@osumc.edu.
Diagn Pathol ; 9: 147, 2014 Aug 09.
Article in En | MEDLINE | ID: mdl-25108298

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Inclusion Bodies / Adrenal Glands / Mineralocorticoid Receptor Antagonists / Hyperaldosteronism / Hypertension Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diagn Pathol Journal subject: PATOLOGIA Year: 2014 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Inclusion Bodies / Adrenal Glands / Mineralocorticoid Receptor Antagonists / Hyperaldosteronism / Hypertension Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diagn Pathol Journal subject: PATOLOGIA Year: 2014 Type: Article